more reasons to limit the use of PPIs

April 2011

See updated FDA information concerning the association of C. difficile and PPIs

You'll see more reasons to limit the use of PPIs.

PPIs (omeprazole, etc) are already associated with a higher risk of pneumonia...Clostridium difficile diarrhea...and fractures. They might also decrease the ability of bisphosphonates to prevent fractures.

Now new Rx labeling will warn that long-term use of PPIs may cause hypomagnesemia...possibly by decreasing magnesium absorption.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote